Featuring Jeff Stravers, virtual chief information officer at ANATOMY_IT.
Featuring Jeff Stravers, virtual...
Health care cybersecurity is an increasing priority as cyber criminals’ tactics become more sophisticated and data breaches can erode patient trust and jeopardize patient safety.
Health care cybersecurity is an increasing priority as cyber criminals’ tactics become more sophisticated and data breaches can erode patient trust and jeopardize patient safety.
In this episode, Dr Gary Owens explores the reasons behind lower vaccine adherence among immunocompromised patients and compares the efficacy of mRNA-1273 and BNT162b2 vaccines for this population, offering insights into factors to consider...
In this episode, Dr Gary Owens explores the reasons behind lower vaccine adherence among immunocompromised patients and compares the efficacy of mRNA-1273 and BNT162b2 vaccines for this population, offering insights into factors to consider...
In this interview, Dr Colin Banas, Chief Medical Officer for DrFirst, discusses the challenges in health care data management, the importance of semantic interoperability, and how clinical-grade AI can improve medication safety and patient...
In this interview, Dr Colin Banas, Chief Medical Officer for DrFirst, discusses the challenges in health care data management, the importance of semantic interoperability, and how clinical-grade AI can improve medication safety and patient...
Derek Streat, Co-Founder, CEO, and Chairman of DexCare, joins us today to learn about how DexCare technology’s Get Care Now program in partnership with UR Medicine is finding ways to virtually connect patients with providers faster.
Derek Streat, Co-Founder, CEO, and Chairman of DexCare, joins us today to learn about how DexCare technology’s Get Care Now program in partnership with UR Medicine is finding ways to virtually connect patients with providers faster.
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Norm Smith, principal payer market research consultant, predicts how payment and patient access strategies may shift once COVID-19 vaccines hit the commercial market and coverage requirements set during the public health emergency expire.
Marcelo Bigal, MD, PhD, chief executive officer, Ventus Therapeutics, discusses a drug discovery platform called ReSOLVE and speaks broadly about how innovations in technology can facilitate faster, more efficient drug development.
Marcelo Bigal, MD, PhD, chief executive officer, Ventus Therapeutics, discusses a drug discovery platform called ReSOLVE and speaks broadly about how innovations in technology can facilitate faster, more efficient drug development.
Gregg Miller, MD, chief medical officer, Vituity, offers his insights on how the combination of COVID-19, respiratory syncytial virus, and influenza is hitting health systems, as well as what actions can be taken to promote provider wellness...
Gregg Miller, MD, chief medical officer, Vituity, offers his insights on how the combination of COVID-19, respiratory syncytial virus, and influenza is hitting health systems, as well as what actions can be taken to promote provider wellness...
Chuck Thigpen, PhD, PT, ATC, clinical research scientist, ATI Physical Therapy, reviews the updated guidance on pain management from the Centers for Disease Control and Prevention, as well as how patients and payers typically cover the costs...
Chuck Thigpen, PhD, PT, ATC, clinical research scientist, ATI Physical Therapy, reviews the updated guidance on pain management from the Centers for Disease Control and Prevention, as well as how patients and payers typically cover the costs...
Alan Vernon, vice president of health care solutions, CQ Fluency, reviews how many people in the United States do not speak English as their primary language and offers advice for payers and providers to keep patients engaged in their care.
Alan Vernon, vice president of health care solutions, CQ Fluency, reviews how many people in the United States do not speak English as their primary language and offers advice for payers and providers to keep patients engaged in their care.
Alex Bacchetti, executive lead of the Center of Operational Transformation, AVIA, shares staffing ideas and technological solutions for health systems to improve recruiting and alleviate burnout now that the pandemic has exacerbated the labor...
Alex Bacchetti, executive lead of the Center of Operational Transformation, AVIA, shares staffing ideas and technological solutions for health systems to improve recruiting and alleviate burnout now that the pandemic has exacerbated the labor...
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore outlines how a rapidly expanding atopic dermatitis pipeline is intensifying competition, reshaping payer strategies, and raising the bar for new therapies.
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore of Clarivate’s market access team discussed the evolving migraine treatment landscape, highlighting the maturation of the acute and prophylactic markets, the emergence of new therapies such as triptan-COX-2 combinations, gepants,...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
Roy Moore, a market access expert, discusses the evolving asthma drug pipeline, highlighting upcoming therapies—including Breztri, depemokimab, and masitinib—their potential to improve adherence and outcomes, payer considerations around cost...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this edition of Pipeline Projections, Roy Moore breaks down the rapidly evolving landscape of multiple sclerosis treatments—highlighting the shift from injectables to orals, the rise of monoclonal antibodies, and the promise of innovative...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
In this episode of Pipeline Projections, Roy Moore—Senior Healthcare Research & Data Analyst at Clarivate—discusses the expanding biosimilar pipeline for autoimmune diseases. He highlights recent FDA approvals, formulary and pricing...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
The US Department of Health and Human Services (HHS) has formally scrapped its 340B Rebate Model Pilot Program following a series of court rulings that blocked its implementation—signaling a significant pause in one of the most closely...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
On February 3, 2026, President Donald Trump signed a broad government funding package that includes multi-year extensions for Medicare teleath and hospital-at-home programs, new oversight requirements for pharmacy benefit managers (PBMs), and...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...